Clinical Trial Update: Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding

View source ↗

Summary

Completed AstraZeneca-sponsored study evaluating the incidence of drug-induced upper gastrointestinal bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Gastrointestinal Bleeding

Snippet

Sponsor: AstraZeneca | Conditions: Upper Gastrointestinal Bleeding | Status: COMPLETED